Don't Just Read the News, Understand It.
Published loading...Updated

Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach

Summary by Globe Newswire
MEDIA RELEASE Investment marks latest step in strategic plan to capture significant part of unprecedented biosimilar patent-expiry market opportunity of...

10 Articles

All
Left
7
Center
1
Right
Globe NewswireGlobe Newswire
+8 Reposted by 8 other sources
Center

Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach

MEDIA RELEASE Investment marks latest step in strategic plan to capture significant part of unprecedented biosimilar patent-expiry market opportunity of...

Sandoz is expanding its presence in Slovenia. The Basel-based generic drug giant has launched construction of a new biosimilar production center in Brnik, an investment of $440 million.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 88% of the sources lean Left
88% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Cambridge Times broke the news in Cambridge, Canada on Tuesday, July 1, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.